Latest Life Technologies Corp (LIFE) Headlines
Post# of 52
Posted On: 03/13/2014 10:34:05 AM
Latest Life Technologies Corp (LIFE) Headlines
IntegenX Announces Approval to Upload DNA Profiles From the RapidHIT(R) System to the National Database
Marketwire - 1 hr 31 mins ago
IntegenX Inc., the market leader in Rapid Human DNA identification, has met the FBI guidelines to upload directly to the NDIS system, known arrestee and convicted offender DNA profiles, as well as casework known samples, generated with the RapidHIT System using Life Technologies GlobalFiler Express kits from Thermo Fisher Scientific.
Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016
M2 - Thu Mar 13, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bgc2v8/global) has announced the addition of the "Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016" report to their offering. One of the main trends witnessed in the Global Electrophoresis Equipment market is the increase in mergers and acquisitions. The Global Electrophoresis Equipment market was marked by a number of mergers and acquisitions by leading vendors. These mergers and acquisitions are done with an intention to increase the vendors' global presence, prevent the loss of patents, and achieve economies of scale. For instance, in 2011, Danaher Corp. acquired Beckman Coulter, which has a wide product portfolio of laboratory instruments. In addition, Agilent Technologies Inc. acquired Dako A/S in July 2012 and Accelicon Technologies Inc. in February 2012. According to the report, one of the main factors driving the market is the Increase in Technological Innovations. The latest technological advancements in various healthcare operations and the sophisticated approaches used in them have increased the demand for electrophoresis equipment. New technologies have helped improve the accuracy, cost, sensitivity, and analysis speed of electrophoresis equipment. Further, the report states that one of the main challenges is the intense competition among vendors. The Global Electrophoresis Equipment market is highly fragmented because of the presence of a large number of vendors. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - Agilent Technologies Inc. - Bio-Rad Laboratories Inc. - C.B.S Scientific Inc. - GE Healthcare Ltd. - Helena Laboratories Corp. - Hoefer Inc. - Life Technologies Corp. - Lonza Group AG - PerkinElmer Inc. - SERVA Electrophoresis GmbH - Sebia S.A. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/bgc2v8/global
Life Technologies Leads Latin American Next-Generation Sequencing: Kalorama Report
PRWeb - Tue Mar 11, 9:19AM CDT
A majority of the next-generation sequencing systems installed in Latin America are of the Life Technologies brand, according to a recent report by Kalorama Information with VA Consultora y Asociados. Kalorama and VA Consultora y Asociados say that the Carlsbad, CA-based company leads its rivals Roche and Illumina in this region. The finding was made in the report, "Next-Generation Sequencing in Latin America".
Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018
M2 - Tue Mar 11, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dp8rj/cancertumor) has announced the addition of the "Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018" report to their offering. The global tumor profiling market is anticipated to reach $35.03 billion by 2018 growing at a CAGR of 18.50%. The market is divided by geography (North America, Europe, Asia-Pacific, and Rest of the World), applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, and Research Applications), technologies (Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray) and segments (Genomics, Proteomics, Metabolomics, and Epigenetics). Further, each application, technology, and segment type is broken down by geography, with an exhaustive revenue analysis for the entire forecast period. Of the above mentioned applications, Personalized Medicine is the largest revenue sector and will be the fastest-growing segment. The cancer profiling market is driven mainly by the rising number of cancer cases. Technological advancements to identify the exact cause of the condition are considered as the second major driver. Additionally, demand for safer and cost-effective treatment further drives the market. The rapid growth of the tumor profiling market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research applications will further enhance its market growth. The current approach of cancer profiling in targeted therapy and personalized medicine for cancer has the potential to address the current demands and fill the gaps in the healthcare industry. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Tumor Profiling Technology Landscape 4 Tumor Profiling Research Portfolio 5 Value Chain Analysis 6 Market Landscape Analysis 7 Technology Adoption And Development Potential, By Geography 8 Technology Investment Analysis 9 Competitive Landscape Analysis 10 Patent Analysis 11 Analyst Insights And Recommendations 12 Company Profiles Companies Mentioned: - Agendia Nv - Biotheranostics - Boreal Genomics, Inc - Caris Life Sciences - Genomic Health, Inc - Illumina, Inc - Life Technologies Corporation - Nanostring Technologies - Neogenomics Laboratories - Oncopath Laboratory - Oxford Gene Technology Ltd - Precision Therapeutics, Inc - Proteome Sciences Plc - Rational Therapeutics - Ribomed Biotechnologies For more information visit http://www.researchandmarkets.com/research/9d...ancertumor
Concise Analysis of the International Agricultural and Environmental Diagnostics Market
M2 - Tue Mar 11, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhcgt6/agricultural_and) has announced the addition of the "Concise Analysis of the International Agricultural and Environmental Diagnostics Market" report to their offering. This report analyzes the worldwide markets for Agricultural and Environmental Diagnostics in US$ Thousand by the following Product Segments: Food Residue Testing, Environmental Residue Testing, and Food Microbiology Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 139 companies including many key and niche players such as: - 3M company - biomerieux SA - Charm Sciences - Idexx Laboratories, Inc. - Life Technologies Corporation - Neogen Corporation - PerkinElmer, Inc. - R-Biopharm AG - Romer Labs? Diagnostic GmbH - Thermo Fisher Scientific, Inc. - VICAM LP - BioControl Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations II. Executive Summary 1. INDUSTRY OVERVIEW 2. FOOD SAFETY TESTING: TRENDS AND ISSUES 3. REGULATORY ENVIRONMENT 4. PRODUCT OVERVIEW 5. GMO TESTING 6. REVIEW OF SELECT TECHNOLOGIES FOR AGRICULTURAL AND ENVIRONMENTAL DIAGNOSTICS 7. PRODUCT INTRODUCTIONS/INNOVATIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 139 (including Divisions/Subsidiaries - 162) - The United States (88) - Canada (5) - Japan (4) - Europe (48) - France (2) - Germany (7) - The United Kingdom (20) - Spain (1) - Rest of Europe (18) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/jh...ltural_and
NGS Market (Next Generation Sequencing Industry) to Grow at a CAGR of 16.3% to 2017
M2 - Mon Mar 10, 4:51AM CDT
RnRMarketResearch.com adds "Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017" report to its research database.
2014 Mesenchymal Stem Cells Global Strategic Business Report - Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality
M2 - Mon Mar 10, 4:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hz38cb/mesenchymal_stem) has announced the addition of the "Mesenchymal Stem Cells - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Mesenchymal Stem Cells (MSCs) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. MARKET DRIVERS, TRENDS & ISSUES - Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies - Adult Stem Cells Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research - Adult Stem Cells and Embryonic Stem Cells - A Comparison - MSCs versus Embryonic or Induced Pluripotent Stem Cells - MSC Therapies Immune to Ethical Issues Applicable to Embryonic Stem Cells - MSCs - A Potential Vehicle for 'Targeted Drug Delivery' - Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements - Major Challenges Confronting Mesenchymal Stem Cell Market 3. STEM CELL MARKET - A MACRO PERSPECTIVE 4. REVIEW OF SELECT MAJOR STEM CELL VARIANTS - Adult Stem Cells - A Low Risk Investment - Adult Stem Cells Garner More Investments for Research - Low Versatility - A Major Limiting Factor of Adult Stem Cells - Hematopoietic Stem Cells - Enjoying Enduring Success - Restraining Factors - Induced Pluripotent Stem Cells - An Alternative to ESCs - A Peek into the Discovery of iPS - Drug Development - A Major Application for iPS - Use of iPS for Regenerative Medicine - Establishing iPS Cell Banks - Intractable and Congenital Disease Treatments - Embryonic Stem Cells to Transfigure Medicine - Ethical Issues and Technical Hurdles Bog Down hESC Research - Lack of Safety and Efficacy Data - A Key Concern 5. MESENCHYMAL STEM CELL RESEARCH BY APPLICATION 6. PRODUCT OVERVIEW 7. PRODUCT INNOVATIONS/LAUNCHES 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Profiled The report profiles 51 companies including many key and niche players such as: - Aastrom Biosciences - Cell Applications - Celprogen - Cyagen Biosciences - EMD Millipore - Genlantis - Life Technologies - Lonza Group - Mesoblast - Neuromics - Osiris Therapeutics - Orthofix International - PromoCell - R&D Systems - ScienCell Research Laboratories - Stemcell Technologies - Stemedica Cell Technologies - StemGenesis - Trevigen - Vitro Biopharma For more information visit http://www.researchandmarkets.com/research/hz...hymal_stem About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Company Profile for Thermo Fisher Scientific
Business Wire - Fri Mar 07, 9:40AM CST
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Our four premier brands - Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services - offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.
Global Flow Cytometry (Products, Application, Technology, and Users) Market Report 2012-2020
M2 - Thu Mar 06, 11:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/hrg48g/flow_cytometry) has announced the addition of the "Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020" report to their offering. The flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9% Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches. KEY MARKET SEGMENTS BY PRODUCT - FC instruments - Reagents - Consumables - Software - Services - Accessories BY TECHNOLOGY - Cell based Technologies - Bead-based Technologies BY APPLICATION - Clinical - Apoptosis - Cell Cycle Analysis - Cell sorting - Cell Viability - Research Fields - Organ transplantation - Cancer - Immunodeficiency Disease - Hematology Haematological Malignancies BY END USERS - Commercial Organizations - Hospitals - Academic Institutes - Medical Schools - Clinical Testing Labs - Others KEY AUDIENCES: - Clinical institutes - Research institutes - Pharma and biotech companies - Academic institutes Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Flow Cytometry Market Overview Chapter 4 Flow Cytometry Market By Product Chapter 5 Flow Cytometry Market By Technology Chapter 6 Flow Cytometry Market By Application Chapter 7 Flow Cytometry Market By End User Chapter 8 Flow Cytometry Market By Geography Chapter 9 Company Profiles - Advanced Analytical Technologies Inc (AATI) - Amnis Corporation - Beckman Coulter - Becton - Dickinson & Co. - Ebioscience Inc. - Inc. - Life Technologies Corporation - Luminex Corporation - Merck Millipore - Morphosys AG - Partec GmbH For more information visit http://www.researchandmarkets.com/research/hr..._cytometry
On-X Life Technologies to launch its On-X(R) Plus 1.5(TM) Aortic Heart Valve at Annual Meeting of the Society for Cardiothoracic Surgery (SCS) in Great Britain & Ireland
Business Wire - Wed Mar 05, 3:48PM CST
Privately held On-X(R) Life Technologies Inc. (On-X LTI) announced today that it will launch its European marketing campaign for the On-X Plus 1.5 Aortic Heart Valve in concert with its Great Britain distributor Vascutek Corp. at the Annual Meeting & Cardiothoracic Forum of the Society for Cardiothoracic Surgery in Great Britain & Ireland, March 10-12, Edinburgh, Scotland.
CollabRx Appoints Clifford Baron as Chief Operating Officer
GlobeNewswire - Wed Mar 05, 8:01AM CST
CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of Clifford Baron, PhD as Vice President and Chief Operating Officer. Mr. Baron's most recent position was with Accelrys, Inc. a $160M+ global software provider serving pharmaceutical, biotechnology, chemical, and materials corporations.
Intrexon Strengthens Leadership to Further Advance Company's Environment Sector
PR Newswire - Tue Mar 04, 7:30AM CST
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Nir Nimrodi, currently Vice President and General Manager of Food Safety and Animal Health at Life Technologies, Inc., now part of Thermo Fisher Scientific, to head Intrexon's Environment Sector, reporting to Chairman and Chief Executive Officer Randal J. Kirk. Mr. Nimrodi will effectively join Intrexon before the end of the month after leaving his current role at Thermo Fisher Scientific.
Concise Analysis of the Future Prospects of Global Personalized Medicine Market
M2 - Tue Mar 04, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/zpctsr/future_prospects) has announced the addition of the "Concise Analysis of the Future Prospects of Global Personalized Medicine Market" report to their offering. Over the years, the Global Personalized Medicine market has been witnessing the emergence of various tools and technologies from the reputed vendors. For instance, AssureRx Health Inc. launched GeneSightRx ADHD in May 2012, a personalized medicine test for the growing number of children and adults diagnosed with ADHD. Moreover, Bristol-Myers Squibb Co. collaborated with MMRF in December 2012 for advanced personalized medicine for multiple Myeloma. Further, Alacris Theranostics GmbH entered into an agreement with GlaxoSmithKline plc in November 2012 to use ModCell system for early stage cancer research. Further, AltheaDx Inc. launched FLT3 Mutation Assay in October 2012. Agendia N.V. launched ColoPrint microarray-based 18-gene expression signature in June 2012 for predicting the risk of distant recurrence for stage II colon cancer patients. The European Medicines Agency approved Zelboraf, manufactured by F. Hoffmann-La Roche Ltd., in December 2011. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 17. Other Reports in this Series Companies Mentioned: - Abbott Laboratories - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Co. - Celgene Corp. - Daiichi Sankyo Co. Ltd. - Danaher Corp. - Eli Lilly and Co. - Evotec AG - F. Hoffmann-La Roche Ltd. - GE Healthcare Ltd. - Genelex Corp. - GlaxoSmithKline plc - Hologic Inc. - Johnson & Johnson - Laboratory Corporation of America Holdings - Life Technologies Corp. - Merck KGaA - Mitsubishi Tanabe Pharma Corp. - Myriad Genetics Inc. - Novartis AG - Novartis AG - PerkinElmer Inc. - Pfizer Inc. - Pfizer Inc. - Quest Diagnostics Inc. - Sanofi S.A. - Sanofi S.A. - Siemens Healthcare - Sigma-Aldrich Corp. - Takeda Pharmaceutical Co. Ltd. - Teva Pharmaceutical Industries Ltd. - Thermo Fisher Scientific Inc. - Transgenomic Inc. For more information visit http://www.researchandmarkets.com/research/zp..._prospects
Global Proteomics Market 2012-2016: One of the Main Drivers in This Market Is the Increasing Demand for Personalized Medicines
M2 - Fri Feb 28, 10:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/dn2hwq/global_proteomics) has announced the addition of the "Global Proteomics Market 2012-2016" report to their offering. The analysts forecast the Global Proteomics market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicines. The Global Proteomics market has also been witnessing a shift from genomics to proteomics. However, the intense competition among vendors could pose a challenge to the growth of this market. The key vendors dominating this space are Thermo Fischer Scientific Inc., Agilent Technologies Inc., Life Technologies Corp., and Danaher Corp. The other vendors mentioned in the report are Sigma-Aldrich Corp., Roche Diagnostics Corp., Betcon Dickinson and Co., Affymetrix Inc., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Abbott Laboratories, GE Healthcare Ltd., Perkin Elmer Inc., Xencor Inc., Cellzome AG, Waters Corp., Dionex Corp., and Bruker Daltonics Inc. Commenting on the report, an analyst from the Healthcare team said: ''One of the recent trends being witnessed in the Global Proteomics market is the growing popularity of proteomic analysis as compared to genomic analysis. Both genomics and proteomics find application in drug discovery, disease diagnosis, and drug development. Genomics is the study of the genes or DNA of an organism. Proteomics, which was introduced after genomics, has become more popular because it offers more benefits than genomics. For instance, proteomic analysis is faster and more effective in terms of data analysis than genomic analysis. Thus, there is a considerable shift from genomics to proteomics for disease diagnosis and drug development. This trend augers well for the growth of the Global Proteomics market during the forecast period.'' For more information visit http://www.researchandmarkets.com/research/dn...proteomics About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market
M2 - Fri Feb 28, 5:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zjkz2c/enzymelinked) has announced the addition of the "Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market" report to their offering. This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousand by the following Product Segments: ELISA Kits, and ELISA Development Sets and Antibody Pairs. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 110 companies including many key and niche players such as: - American Laboratory Products Company - BD Biosciences - BioMerieux SA - Bio-Rad Laboratories, Inc. - EMD Millipore Corp. - Life Technologies Corporation - Ortho-Clinical Diagnostics, Inc. - R&D Systems, Inc. - Thermo Fisher Scientific, Inc. - ZEUS Scientific, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Immunochemistry - An Introduction 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 110 (including Divisions/Subsidiaries - 117) - The United States (76) - Canada (3) - Japan (1) - Europe (28) - France (1) - Germany (8) - The United Kingdom (8) - Spain (1) - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/zj...zymelinked
Upland Software Announces Fourth Quarter 2013 Highlights
PRWeb - Thu Feb 27, 11:10AM CST
Upland Software, Inc., a leading cloud provider of enterprise work management software, today announced highlights for the quarter ended December 31, 2013.
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
US Automated Microbiology Market 2014
M2 - Wed Feb 26, 9:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/p8czll/us_automated) has announced the addition of the "US Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. United States Automated Microbiology Market 2014 is a new analysis of major business opportunities emerging in the US automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Specimen Types - Urine - Sterile Fluids: Blood, Serum, CSF - Throat Swabs, Respiratory Secretions - Genital Secretions - Stool - Abscess/Wound - Sputum - Saliva Applications - Microbial Identification - Antibiotic Susceptibility - Urine Screening - Blood Cultures Review of Major Automated Systems - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers. The report profiles analyzers manufactured by: Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh. Technology Review - Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. - Global listings of companies developing or marketing microbiology products by individual test. For more information visit http://www.researchandmarkets.com/research/p8..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The Next Generation Sequencing (NGS) Market is Poised to Reach $2.7 billion by 2017
M2 - Wed Feb 26, 8:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/4mskzv/next_generation) has announced the addition of the "Next Generation Sequencing (NGS) Market - Global Forecast to 2017" report to their offering. This research report categorizes and analyzes the global Next Generation Sequencing (NGS) market on the basis of steps in the NGS workflow and NGS applications. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario. The next generation sequencing (NSG) market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms. Key Findings: - The NGS pre-sequencing (sample - preparation) segment represents a promising area in the overall market owing to the need for automation and standardized solutions for sample preparation. The market for sequencing platforms has been very dynamic. Some revolutionary platforms like GA IIx (Illumina) and SOLiD Series (Life Technologies) have taken a setback and newer platforms like MiSeq and Ion Torrent Proton are gaining market dominance. - Along with large research and academic institutions that serve as a key end-user for the NGS market, NGS technologies are recently being developed for use in clinical set-ups and presently much of the NGS effort is focused on cancer. - The factors driving the NGS market include decreasing costs, improved turnaround time, increase in number of applications, and replacement of microarray applications by NGS. Personalized medicine and biomarker discovery open avenues for investments, thus offering a growth opportunity for the NGS market. However, the causes for hindrance to growth will be the high reliability on grants by research institutes, accuracy and standardization concerns, data storage problems, and issues in interpretation of complex data. Companies Mentioned: - Agilent Technologies, Inc - BGI (Beijing Genomics Institute) - Biomatters, Ltd - CLC Bio - Dnastar, Inc - EMC Corporation - GATC biotech AG - Genomatix Software GMBH - Illumina, Inc - Knome, Inc - Life Sciences Corporation (A Roche Company) - Life Technologies Corporation - Macrogen, Inc - Ocimum Biosolutions, Ltd - Oxford Nanorpore Technologies, Ltd - Pacific Biosciences - Partek Incorporated - Perkinelmer, Inc - Qiagen NV - Strand Life Sciences Pvt Ltd For more information visit http://www.researchandmarkets.com/research/4m...generation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
IntegenX Announces Approval to Upload DNA Profiles From the RapidHIT(R) System to the National Database
Marketwire - 1 hr 31 mins ago
IntegenX Inc., the market leader in Rapid Human DNA identification, has met the FBI guidelines to upload directly to the NDIS system, known arrestee and convicted offender DNA profiles, as well as casework known samples, generated with the RapidHIT System using Life Technologies GlobalFiler Express kits from Thermo Fisher Scientific.
Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016
M2 - Thu Mar 13, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bgc2v8/global) has announced the addition of the "Concise Analysis of the International Electrophoresis Equipment Market - Forecasts to 2016" report to their offering. One of the main trends witnessed in the Global Electrophoresis Equipment market is the increase in mergers and acquisitions. The Global Electrophoresis Equipment market was marked by a number of mergers and acquisitions by leading vendors. These mergers and acquisitions are done with an intention to increase the vendors' global presence, prevent the loss of patents, and achieve economies of scale. For instance, in 2011, Danaher Corp. acquired Beckman Coulter, which has a wide product portfolio of laboratory instruments. In addition, Agilent Technologies Inc. acquired Dako A/S in July 2012 and Accelicon Technologies Inc. in February 2012. According to the report, one of the main factors driving the market is the Increase in Technological Innovations. The latest technological advancements in various healthcare operations and the sophisticated approaches used in them have increased the demand for electrophoresis equipment. New technologies have helped improve the accuracy, cost, sensitivity, and analysis speed of electrophoresis equipment. Further, the report states that one of the main challenges is the intense competition among vendors. The Global Electrophoresis Equipment market is highly fragmented because of the presence of a large number of vendors. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - Agilent Technologies Inc. - Bio-Rad Laboratories Inc. - C.B.S Scientific Inc. - GE Healthcare Ltd. - Helena Laboratories Corp. - Hoefer Inc. - Life Technologies Corp. - Lonza Group AG - PerkinElmer Inc. - SERVA Electrophoresis GmbH - Sebia S.A. - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/bgc2v8/global
Life Technologies Leads Latin American Next-Generation Sequencing: Kalorama Report
PRWeb - Tue Mar 11, 9:19AM CDT
A majority of the next-generation sequencing systems installed in Latin America are of the Life Technologies brand, according to a recent report by Kalorama Information with VA Consultora y Asociados. Kalorama and VA Consultora y Asociados say that the Carlsbad, CA-based company leads its rivals Roche and Illumina in this region. The finding was made in the report, "Next-Generation Sequencing in Latin America".
Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018
M2 - Tue Mar 11, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dp8rj/cancertumor) has announced the addition of the "Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018" report to their offering. The global tumor profiling market is anticipated to reach $35.03 billion by 2018 growing at a CAGR of 18.50%. The market is divided by geography (North America, Europe, Asia-Pacific, and Rest of the World), applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, and Research Applications), technologies (Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray) and segments (Genomics, Proteomics, Metabolomics, and Epigenetics). Further, each application, technology, and segment type is broken down by geography, with an exhaustive revenue analysis for the entire forecast period. Of the above mentioned applications, Personalized Medicine is the largest revenue sector and will be the fastest-growing segment. The cancer profiling market is driven mainly by the rising number of cancer cases. Technological advancements to identify the exact cause of the condition are considered as the second major driver. Additionally, demand for safer and cost-effective treatment further drives the market. The rapid growth of the tumor profiling market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research applications will further enhance its market growth. The current approach of cancer profiling in targeted therapy and personalized medicine for cancer has the potential to address the current demands and fill the gaps in the healthcare industry. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Tumor Profiling Technology Landscape 4 Tumor Profiling Research Portfolio 5 Value Chain Analysis 6 Market Landscape Analysis 7 Technology Adoption And Development Potential, By Geography 8 Technology Investment Analysis 9 Competitive Landscape Analysis 10 Patent Analysis 11 Analyst Insights And Recommendations 12 Company Profiles Companies Mentioned: - Agendia Nv - Biotheranostics - Boreal Genomics, Inc - Caris Life Sciences - Genomic Health, Inc - Illumina, Inc - Life Technologies Corporation - Nanostring Technologies - Neogenomics Laboratories - Oncopath Laboratory - Oxford Gene Technology Ltd - Precision Therapeutics, Inc - Proteome Sciences Plc - Rational Therapeutics - Ribomed Biotechnologies For more information visit http://www.researchandmarkets.com/research/9d...ancertumor
Concise Analysis of the International Agricultural and Environmental Diagnostics Market
M2 - Tue Mar 11, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhcgt6/agricultural_and) has announced the addition of the "Concise Analysis of the International Agricultural and Environmental Diagnostics Market" report to their offering. This report analyzes the worldwide markets for Agricultural and Environmental Diagnostics in US$ Thousand by the following Product Segments: Food Residue Testing, Environmental Residue Testing, and Food Microbiology Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 139 companies including many key and niche players such as: - 3M company - biomerieux SA - Charm Sciences - Idexx Laboratories, Inc. - Life Technologies Corporation - Neogen Corporation - PerkinElmer, Inc. - R-Biopharm AG - Romer Labs? Diagnostic GmbH - Thermo Fisher Scientific, Inc. - VICAM LP - BioControl Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations II. Executive Summary 1. INDUSTRY OVERVIEW 2. FOOD SAFETY TESTING: TRENDS AND ISSUES 3. REGULATORY ENVIRONMENT 4. PRODUCT OVERVIEW 5. GMO TESTING 6. REVIEW OF SELECT TECHNOLOGIES FOR AGRICULTURAL AND ENVIRONMENTAL DIAGNOSTICS 7. PRODUCT INTRODUCTIONS/INNOVATIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 139 (including Divisions/Subsidiaries - 162) - The United States (88) - Canada (5) - Japan (4) - Europe (48) - France (2) - Germany (7) - The United Kingdom (20) - Spain (1) - Rest of Europe (18) - Asia-Pacific (Excluding Japan) (16) - Latin America (1) For more information visit http://www.researchandmarkets.com/research/jh...ltural_and
NGS Market (Next Generation Sequencing Industry) to Grow at a CAGR of 16.3% to 2017
M2 - Mon Mar 10, 4:51AM CDT
RnRMarketResearch.com adds "Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017" report to its research database.
2014 Mesenchymal Stem Cells Global Strategic Business Report - Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality
M2 - Mon Mar 10, 4:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hz38cb/mesenchymal_stem) has announced the addition of the "Mesenchymal Stem Cells - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Mesenchymal Stem Cells (MSCs) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. MARKET DRIVERS, TRENDS & ISSUES - Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies - Adult Stem Cells Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research - Adult Stem Cells and Embryonic Stem Cells - A Comparison - MSCs versus Embryonic or Induced Pluripotent Stem Cells - MSC Therapies Immune to Ethical Issues Applicable to Embryonic Stem Cells - MSCs - A Potential Vehicle for 'Targeted Drug Delivery' - Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements - Major Challenges Confronting Mesenchymal Stem Cell Market 3. STEM CELL MARKET - A MACRO PERSPECTIVE 4. REVIEW OF SELECT MAJOR STEM CELL VARIANTS - Adult Stem Cells - A Low Risk Investment - Adult Stem Cells Garner More Investments for Research - Low Versatility - A Major Limiting Factor of Adult Stem Cells - Hematopoietic Stem Cells - Enjoying Enduring Success - Restraining Factors - Induced Pluripotent Stem Cells - An Alternative to ESCs - A Peek into the Discovery of iPS - Drug Development - A Major Application for iPS - Use of iPS for Regenerative Medicine - Establishing iPS Cell Banks - Intractable and Congenital Disease Treatments - Embryonic Stem Cells to Transfigure Medicine - Ethical Issues and Technical Hurdles Bog Down hESC Research - Lack of Safety and Efficacy Data - A Key Concern 5. MESENCHYMAL STEM CELL RESEARCH BY APPLICATION 6. PRODUCT OVERVIEW 7. PRODUCT INNOVATIONS/LAUNCHES 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Profiled The report profiles 51 companies including many key and niche players such as: - Aastrom Biosciences - Cell Applications - Celprogen - Cyagen Biosciences - EMD Millipore - Genlantis - Life Technologies - Lonza Group - Mesoblast - Neuromics - Osiris Therapeutics - Orthofix International - PromoCell - R&D Systems - ScienCell Research Laboratories - Stemcell Technologies - Stemedica Cell Technologies - StemGenesis - Trevigen - Vitro Biopharma For more information visit http://www.researchandmarkets.com/research/hz...hymal_stem About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Company Profile for Thermo Fisher Scientific
Business Wire - Fri Mar 07, 9:40AM CST
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Our four premier brands - Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services - offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.
Global Flow Cytometry (Products, Application, Technology, and Users) Market Report 2012-2020
M2 - Thu Mar 06, 11:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/hrg48g/flow_cytometry) has announced the addition of the "Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020" report to their offering. The flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9% Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches. KEY MARKET SEGMENTS BY PRODUCT - FC instruments - Reagents - Consumables - Software - Services - Accessories BY TECHNOLOGY - Cell based Technologies - Bead-based Technologies BY APPLICATION - Clinical - Apoptosis - Cell Cycle Analysis - Cell sorting - Cell Viability - Research Fields - Organ transplantation - Cancer - Immunodeficiency Disease - Hematology Haematological Malignancies BY END USERS - Commercial Organizations - Hospitals - Academic Institutes - Medical Schools - Clinical Testing Labs - Others KEY AUDIENCES: - Clinical institutes - Research institutes - Pharma and biotech companies - Academic institutes Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Flow Cytometry Market Overview Chapter 4 Flow Cytometry Market By Product Chapter 5 Flow Cytometry Market By Technology Chapter 6 Flow Cytometry Market By Application Chapter 7 Flow Cytometry Market By End User Chapter 8 Flow Cytometry Market By Geography Chapter 9 Company Profiles - Advanced Analytical Technologies Inc (AATI) - Amnis Corporation - Beckman Coulter - Becton - Dickinson & Co. - Ebioscience Inc. - Inc. - Life Technologies Corporation - Luminex Corporation - Merck Millipore - Morphosys AG - Partec GmbH For more information visit http://www.researchandmarkets.com/research/hr..._cytometry
On-X Life Technologies to launch its On-X(R) Plus 1.5(TM) Aortic Heart Valve at Annual Meeting of the Society for Cardiothoracic Surgery (SCS) in Great Britain & Ireland
Business Wire - Wed Mar 05, 3:48PM CST
Privately held On-X(R) Life Technologies Inc. (On-X LTI) announced today that it will launch its European marketing campaign for the On-X Plus 1.5 Aortic Heart Valve in concert with its Great Britain distributor Vascutek Corp. at the Annual Meeting & Cardiothoracic Forum of the Society for Cardiothoracic Surgery in Great Britain & Ireland, March 10-12, Edinburgh, Scotland.
CollabRx Appoints Clifford Baron as Chief Operating Officer
GlobeNewswire - Wed Mar 05, 8:01AM CST
CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of Clifford Baron, PhD as Vice President and Chief Operating Officer. Mr. Baron's most recent position was with Accelrys, Inc. a $160M+ global software provider serving pharmaceutical, biotechnology, chemical, and materials corporations.
Intrexon Strengthens Leadership to Further Advance Company's Environment Sector
PR Newswire - Tue Mar 04, 7:30AM CST
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Nir Nimrodi, currently Vice President and General Manager of Food Safety and Animal Health at Life Technologies, Inc., now part of Thermo Fisher Scientific, to head Intrexon's Environment Sector, reporting to Chairman and Chief Executive Officer Randal J. Kirk. Mr. Nimrodi will effectively join Intrexon before the end of the month after leaving his current role at Thermo Fisher Scientific.
Concise Analysis of the Future Prospects of Global Personalized Medicine Market
M2 - Tue Mar 04, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/zpctsr/future_prospects) has announced the addition of the "Concise Analysis of the Future Prospects of Global Personalized Medicine Market" report to their offering. Over the years, the Global Personalized Medicine market has been witnessing the emergence of various tools and technologies from the reputed vendors. For instance, AssureRx Health Inc. launched GeneSightRx ADHD in May 2012, a personalized medicine test for the growing number of children and adults diagnosed with ADHD. Moreover, Bristol-Myers Squibb Co. collaborated with MMRF in December 2012 for advanced personalized medicine for multiple Myeloma. Further, Alacris Theranostics GmbH entered into an agreement with GlaxoSmithKline plc in November 2012 to use ModCell system for early stage cancer research. Further, AltheaDx Inc. launched FLT3 Mutation Assay in October 2012. Agendia N.V. launched ColoPrint microarray-based 18-gene expression signature in June 2012 for predicting the risk of distant recurrence for stage II colon cancer patients. The European Medicines Agency approved Zelboraf, manufactured by F. Hoffmann-La Roche Ltd., in December 2011. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 17. Other Reports in this Series Companies Mentioned: - Abbott Laboratories - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Co. - Celgene Corp. - Daiichi Sankyo Co. Ltd. - Danaher Corp. - Eli Lilly and Co. - Evotec AG - F. Hoffmann-La Roche Ltd. - GE Healthcare Ltd. - Genelex Corp. - GlaxoSmithKline plc - Hologic Inc. - Johnson & Johnson - Laboratory Corporation of America Holdings - Life Technologies Corp. - Merck KGaA - Mitsubishi Tanabe Pharma Corp. - Myriad Genetics Inc. - Novartis AG - Novartis AG - PerkinElmer Inc. - Pfizer Inc. - Pfizer Inc. - Quest Diagnostics Inc. - Sanofi S.A. - Sanofi S.A. - Siemens Healthcare - Sigma-Aldrich Corp. - Takeda Pharmaceutical Co. Ltd. - Teva Pharmaceutical Industries Ltd. - Thermo Fisher Scientific Inc. - Transgenomic Inc. For more information visit http://www.researchandmarkets.com/research/zp..._prospects
Global Proteomics Market 2012-2016: One of the Main Drivers in This Market Is the Increasing Demand for Personalized Medicines
M2 - Fri Feb 28, 10:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/dn2hwq/global_proteomics) has announced the addition of the "Global Proteomics Market 2012-2016" report to their offering. The analysts forecast the Global Proteomics market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicines. The Global Proteomics market has also been witnessing a shift from genomics to proteomics. However, the intense competition among vendors could pose a challenge to the growth of this market. The key vendors dominating this space are Thermo Fischer Scientific Inc., Agilent Technologies Inc., Life Technologies Corp., and Danaher Corp. The other vendors mentioned in the report are Sigma-Aldrich Corp., Roche Diagnostics Corp., Betcon Dickinson and Co., Affymetrix Inc., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Abbott Laboratories, GE Healthcare Ltd., Perkin Elmer Inc., Xencor Inc., Cellzome AG, Waters Corp., Dionex Corp., and Bruker Daltonics Inc. Commenting on the report, an analyst from the Healthcare team said: ''One of the recent trends being witnessed in the Global Proteomics market is the growing popularity of proteomic analysis as compared to genomic analysis. Both genomics and proteomics find application in drug discovery, disease diagnosis, and drug development. Genomics is the study of the genes or DNA of an organism. Proteomics, which was introduced after genomics, has become more popular because it offers more benefits than genomics. For instance, proteomic analysis is faster and more effective in terms of data analysis than genomic analysis. Thus, there is a considerable shift from genomics to proteomics for disease diagnosis and drug development. This trend augers well for the growth of the Global Proteomics market during the forecast period.'' For more information visit http://www.researchandmarkets.com/research/dn...proteomics About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market
M2 - Fri Feb 28, 5:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zjkz2c/enzymelinked) has announced the addition of the "Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market" report to their offering. This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousand by the following Product Segments: ELISA Kits, and ELISA Development Sets and Antibody Pairs. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 110 companies including many key and niche players such as: - American Laboratory Products Company - BD Biosciences - BioMerieux SA - Bio-Rad Laboratories, Inc. - EMD Millipore Corp. - Life Technologies Corporation - Ortho-Clinical Diagnostics, Inc. - R&D Systems, Inc. - Thermo Fisher Scientific, Inc. - ZEUS Scientific, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Immunochemistry - An Introduction 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 110 (including Divisions/Subsidiaries - 117) - The United States (76) - Canada (3) - Japan (1) - Europe (28) - France (1) - Germany (8) - The United Kingdom (8) - Spain (1) - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/zj...zymelinked
Upland Software Announces Fourth Quarter 2013 Highlights
PRWeb - Thu Feb 27, 11:10AM CST
Upland Software, Inc., a leading cloud provider of enterprise work management software, today announced highlights for the quarter ended December 31, 2013.
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
US Automated Microbiology Market 2014
M2 - Wed Feb 26, 9:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/p8czll/us_automated) has announced the addition of the "US Automated Microbiology Market 2014: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. United States Automated Microbiology Market 2014 is a new analysis of major business opportunities emerging in the US automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Specimen Types - Urine - Sterile Fluids: Blood, Serum, CSF - Throat Swabs, Respiratory Secretions - Genital Secretions - Stool - Abscess/Wound - Sputum - Saliva Applications - Microbial Identification - Antibiotic Susceptibility - Urine Screening - Blood Cultures Review of Major Automated Systems - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers. The report profiles analyzers manufactured by: Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh. Technology Review - Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. - Global listings of companies developing or marketing microbiology products by individual test. For more information visit http://www.researchandmarkets.com/research/p8..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The Next Generation Sequencing (NGS) Market is Poised to Reach $2.7 billion by 2017
M2 - Wed Feb 26, 8:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/4mskzv/next_generation) has announced the addition of the "Next Generation Sequencing (NGS) Market - Global Forecast to 2017" report to their offering. This research report categorizes and analyzes the global Next Generation Sequencing (NGS) market on the basis of steps in the NGS workflow and NGS applications. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario. The next generation sequencing (NSG) market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of sequencing. It is the fastest-growing and most lucrative segment in the genomics space with an estimated growth of 16.3%. The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms. Key Findings: - The NGS pre-sequencing (sample - preparation) segment represents a promising area in the overall market owing to the need for automation and standardized solutions for sample preparation. The market for sequencing platforms has been very dynamic. Some revolutionary platforms like GA IIx (Illumina) and SOLiD Series (Life Technologies) have taken a setback and newer platforms like MiSeq and Ion Torrent Proton are gaining market dominance. - Along with large research and academic institutions that serve as a key end-user for the NGS market, NGS technologies are recently being developed for use in clinical set-ups and presently much of the NGS effort is focused on cancer. - The factors driving the NGS market include decreasing costs, improved turnaround time, increase in number of applications, and replacement of microarray applications by NGS. Personalized medicine and biomarker discovery open avenues for investments, thus offering a growth opportunity for the NGS market. However, the causes for hindrance to growth will be the high reliability on grants by research institutes, accuracy and standardization concerns, data storage problems, and issues in interpretation of complex data. Companies Mentioned: - Agilent Technologies, Inc - BGI (Beijing Genomics Institute) - Biomatters, Ltd - CLC Bio - Dnastar, Inc - EMC Corporation - GATC biotech AG - Genomatix Software GMBH - Illumina, Inc - Knome, Inc - Life Sciences Corporation (A Roche Company) - Life Technologies Corporation - Macrogen, Inc - Ocimum Biosolutions, Ltd - Oxford Nanorpore Technologies, Ltd - Pacific Biosciences - Partek Incorporated - Perkinelmer, Inc - Qiagen NV - Strand Life Sciences Pvt Ltd For more information visit http://www.researchandmarkets.com/research/4m...generation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
(0)
(0)aTyr Pharma, Inc. (ATYR) Stock Research Links
Scroll down for more posts ▼